tiprankstipranks
Finch Therapeutics Group (FNCHQ)
OTHER OTC:FNCHQ
US Market
Want to see FNCHQ full AI Analyst Report?

Finch Therapeutics Group (FNCHQ) Financial Statements

63 Followers

Finch Therapeutics Group Financial Overview

Finch Therapeutics Group's market cap is currently $11.61M. The company's EPS TTM is $; its P/E ratio is ―; Finch Therapeutics Group is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Mar 22Dec 20Dec 19
Income Statement
Total Revenue$ 107.00K$ 861.00K$ 18.53M$ 7.72M$ 10.15M
Gross Profit$ -1.41M$ -4.65M$ -38.75M$ -25.43M$ 9.84M
Operating Income$ -34.00M$ -95.12M$ -59.98M$ -39.44M$ -21.14M
EBITDA$ -32.48M$ -82.69M$ -57.68M$ -38.65M$ -20.66M
Net Income$ -74.75M$ -114.65M$ -58.16M$ -39.25M$ -20.75M
Balance Sheet
Cash & Short-Term Investments$ 25.12M$ 71.04M$ 133.48M$ 99.71M$ 42.19M
Total Assets$ 55.37M$ 162.94M$ 225.37M$ 165.34M$ 103.57M
Total Debt$ 30.13M$ 52.34M$ 6.01M$ 1.81M$ 143.15M
Net Debt$ 5.00M$ -18.70M$ -127.47M$ -97.90M$ 100.96M
Total Liabilities$ 32.49M$ 67.23M$ 23.14M$ 261.06M$ 163.10M
Stockholders' Equity$ 22.89M$ 95.71M$ 202.22M$ -95.72M$ -59.53M
Cash Flow
Free Cash Flow$ -31.50M$ -77.03M$ -83.12M$ -33.96M$ -18.32M
Operating Cash Flow$ -31.50M$ -74.85M$ -67.13M$ -31.33M$ -17.32M
Investing Cash Flow$ 1.33M$ -2.18M$ -15.92M$ -2.63M$ -973.00K
Financing Cash Flow$ -16.16M$ 14.87M$ 119.11M$ 91.47M$ 53.30M
Currency in USD

Finch Therapeutics Group Earnings and Revenue History

Finch Therapeutics Group Debt to Assets

Finch Therapeutics Group Cash Flow

Finch Therapeutics Group Forecast EPS vs Actual EPS